Autres langues MedPacto, Inc.

Actions

A235980

KR7235980000

Recherche biotechnologique et médicale

Cours en clôture Korea S.E. 30/09/2026			Varia. 5j.	Varia. 1 janv.
2 830,00 ^KRW	-2,75%		+3,47%	-57,63%

13/08	MedPacto, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
13/05	MedPacto, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

21/09	MedPacto, Inc.(KOSDAQ:A235980) dropped from S&P Global BMI Index
13/08	MedPacto, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
13/05	MedPacto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
18/03	MedPacto, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
12/11	MedPacto, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
14/08/25	MedPacto, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
15/05/25	MedPacto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
20/03/25	MedPacto, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
14/11/24	MedPacto, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
28/10/24	Chime Biologics and MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing
15/12/23	MedPacto, Inc. announced that it has received KRW 10.85806127 billion in funding from Theragen Etex Co.,Ltd.
13/09/23	South Korean Shares Nearly Unchanged Ahead of US Inflation Data
13/09/23	Medpacto to Raise 115.9 Billion Won via Stock Sale
12/05/23	MedPacto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
24/03/22	Medpacto, Inc. Appoints Timothy R. Allen as Executive Vice President
15/01/21	MedPacto, Inc. announced that it has received KRW 30.0000844 billion in funding
15/01/21	MedPacto, Inc. announced that it has received KRW 70 billion in funding
24/12/20	MedPacto, Inc. announced that it expects to receive KRW 30.0000844 billion in funding
23/12/20	MedPacto, Inc. announced that it expects to receive KRW 70 billion in funding
22/06/20	MedPacto, Inc.(KOSDAQ:A235980) added to S&P Global BMI Index
13/12/19	MedPacto, Inc. has completed an IPO in the amount of KRW 60.44 billion.
13/08/19	MedPacto, Inc. has filed an IPO in the amount of KRW 72.48 billion.
03/01/18	Medpacto, Inc. announced that it has received KRW 999.999 million in funding from UNO & COMPANY Ltd.
02/01/18	Medpacto, Inc. announced that it expects to receive KRW 10,000 million in funding from UNO & COMPANY Ltd.